Franklin, Parlapiano, Turner & Welch’s Chemours CC Stock Holding History

Franklin, Parlapiano, Turner & Welch’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-189	Closed	-$7K	–	62
2017 Q1	$7K	Buy	189 +9	+5%	+$271	﹤0.01%	109
2016 Q4	$4K	Hold	180	–	–	﹤0.01%	113
2016 Q3	$3K	Sell	180 -100	-36%	-$1.14K	﹤0.01%	123
2016 Q2	$2K	Sell	280 -53	-16%	-$472	﹤0.01%	110
2016 Q1	$2K	Hold	333	–	–	﹤0.01%	113
2015 Q4	$2K	Hold	333	–	–	﹤0.01%	116
2015 Q3	$2K	Buy	+333	New	+$3.49K	﹤0.01%	98

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Franklin, Parlapiano, Turner & Welch's CC Position: Q2 2017 in Review

Franklin, Parlapiano, Turner & Welch sold out of Chemours (CC) in Q2 2017, closing a stake of 189 shares — an estimated $7K sold.

Franklin, Parlapiano, Turner & Welch first reported a position in CC in Q3 2015 and held it in 7 quarters. The position peaked at $7K in Q1 2017. 463 funds tracked by Wall St. Rank hold CC as of Q2 2017.

Franklin, Parlapiano, Turner & Welch reported no remaining Chemours position as of Q2 2017 after selling out during the quarter.
Franklin, Parlapiano, Turner & Welch sold 189 Chemours shares in Q2 2017, an estimated $7K.
Franklin, Parlapiano, Turner & Welch first reported a position in Chemours in Q3 2015 and held it in 7 quarters.
Franklin, Parlapiano, Turner & Welch's Chemours position peaked at $7K in Q1 2017.
463 funds tracked by Wall St. Rank held Chemours as of Q2 2017.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2017, filed 17 Jul 2017.